Why the Incannex (ASX:IHL) share price is soaring 13%

The Incannex share price is soaring today as the company mulls a US listing. We take a closer look at its release.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Incannex Healthcare Ltd (ASX: IHL) share price is soaring today as the company announced that it is mulling a US listing. Shares in the small-cap health care stock are currently trading 12.82% higher as a result. This has held Incannex shares to rise to a price of 22 cents.

Why is the Incannex share price flying?

Today the Incannex share price is trading strongly higher. This comes as the company announced that it is intending to list on the US market. The company has executed a binding consulting agreement with EAS Advisors to facilitate the listing.

Incannex noted that the predominant purpose of the arrangement was for EAS to introduce it to US banks and institutions. With the aim of dual listing the company on either the Nasdaq Composite (INDEXNASDAQ: .IXIC) or the NYSE Composite (INDEXNYSEGIS: NYA). While also retaining its listing on the ASX.

It is worth noting that the term of the agreement is 12 months. EAS will be paid both with Incannex options and a standard retainer. The advisory firm is also going to assist with financial modelling, presentation preparation, and external data room maintenance. This will be on top of generating global investor awareness.

Management Comments

CEO and Managing Director of Incannex Healthcare, Joel Latham, welcomed the news by saying:

After several months of getting to know one another, Eddie and EAS have joined our broader team to evaluate opportunities to list IHL securities in the United States on one of the main markets. We have made this decision because of deep investor interest and corporate activity in both cannabinoid-based pharmaceuticals and psychedelic therapeutic endeavours in North America. We're delighted to be working with the team at EAS, which has an excellent track record of growing international awareness for ASX companies.

About the Incannex share price

The Incannex share price has performed well as of late as it recently released positive drug results.

In the last month alone, its shares are up a whopping 37.5%, easily outpacing the All Ordinaries Index (ASX: XAO). Incannex is currently valued at $229.24 million.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Young girl drinking milk showing off muscles.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a great end to the trading week for ASX investors today.

Read more »

Hands reaching high for a trophy with a sunset in the background.
Record Highs

The ASX 200 Index is on its way to another all-time high today. Here's why

These blue chip stocks are driving the index towards a new record today...

Read more »

Group of friends trading stocks on their phones. symbolising the 3 most traded ASX 200 shares today
Share Market News

3 ASX mining stocks topping the most-traded list in October

Chinese stimulus news and company announcements likely contributed to the higher trading activity.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Share Gainers

3 ASX 200 stocks smashing the benchmark this week

These three ASX 200 stocks are leading the charge this week. Here’s how.

Read more »

Two people tired and resting after sports race.
Broker Notes

Fundie rates 2 ASX 200 stocks in short-term pain but with long-term gain potential

Blackwattle Investment Partners sees these 2 ASX 200 stocks as worthy of a buy and hold strategy.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why A2 Milk, EOS, GQG, and Mineral Resources shares are racing higher today

These shares are ending the week strongly. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Megaport, Pilbara Minerals, Vysarn, and WiseTech shares are falling today

These shares are ending the week in the red. But why?

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »